Biotech company CILcare adds four hearing experts to its Scientific Advisory Board: Keith Darrow, Stéphane Maison, Aimo Kannt, and Dona Jayakody. The SAB will help develop CILcare's synaptopathy pipeline, which targets early markers of neurocognitive and inflammatory diseases.